615 related articles for article (PubMed ID: 17558313)
1. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
[TBL] [Abstract][Full Text] [Related]
2. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
[TBL] [Abstract][Full Text] [Related]
4. Retinal pigment epithelial tear after intravitreal bevacizumab injection.
Shah CP; Hsu J; Garg SJ; Fischer DH; Kaiser R
Am J Ophthalmol; 2006 Dec; 142(6):1070-2. PubMed ID: 17157598
[TBL] [Abstract][Full Text] [Related]
5. Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration.
Gelisken F; Ziemssen F; Voelker M; Bartz-Schmidt KU; Inhoffen W
Eye (Lond); 2009 Mar; 23(3):694-702. PubMed ID: 18239678
[TBL] [Abstract][Full Text] [Related]
6. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration.
Spandau UH; Jonas JB
Am J Ophthalmol; 2006 Dec; 142(6):1068-70. PubMed ID: 17157597
[TBL] [Abstract][Full Text] [Related]
7. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration.
Garg S; Brod R; Kim D; Lane RG; Maguire J; Fischer D
Clin Exp Ophthalmol; 2008 Apr; 36(3):252-6. PubMed ID: 18412594
[TBL] [Abstract][Full Text] [Related]
8. Retinal pigment epithelial tear after intravitreal ranibizumab.
Bakri SJ; Kitzmann AS
Am J Ophthalmol; 2007 Mar; 143(3):505-7. PubMed ID: 17317396
[TBL] [Abstract][Full Text] [Related]
9. [Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress].
Kook D; Wolf A; Neubauer AS; Haritoglou C; Priglinger SG; Kampik A; Ulbig MW
Ophthalmologe; 2008 Feb; 105(2):158-64. PubMed ID: 17653552
[TBL] [Abstract][Full Text] [Related]
10. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
Melamud A; Stinnett S; Fekrat S
Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144
[TBL] [Abstract][Full Text] [Related]
11. Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration.
Carvounis PE; Kopel AC; Benz MS
Am J Ophthalmol; 2007 Mar; 143(3):504-5. PubMed ID: 17317395
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
Avery RL; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ
Ophthalmology; 2006 Mar; 113(3):363-372.e5. PubMed ID: 16458968
[TBL] [Abstract][Full Text] [Related]
13. Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Gelisken F; Ziemssen F; Voelker M; Bartz-Schmidt KU
Acta Ophthalmol Scand; 2006 Dec; 84(6):833-4. PubMed ID: 17083554
[No Abstract] [Full Text] [Related]
14. Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease.
Wong LJ; Desai RU; Jain A; Feliciano D; Moshfeghi DM; Sanislo SR; Blumenkranz MS
Retina; 2008 Oct; 28(8):1151-8. PubMed ID: 18685542
[TBL] [Abstract][Full Text] [Related]
15. Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin).
Nicolò M; Ghiglione D; Calabria G
Eur J Ophthalmol; 2006; 16(5):770-3. PubMed ID: 17061236
[TBL] [Abstract][Full Text] [Related]
16. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
[TBL] [Abstract][Full Text] [Related]
17. Retinal pigment epithelium tears following intravitreal ranibizumab therapy.
Kiss C; Michels S; Prager F; Geitzenauer W; Schmidt-Erfurth U
Acta Ophthalmol Scand; 2007 Dec; 85(8):902-3. PubMed ID: 17408387
[TBL] [Abstract][Full Text] [Related]
18. Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment.
Weinberger AW; Thiel M; Mohammadi B; Theofylaktopoulos I; Thumann G; Walter P
Am J Ophthalmol; 2007 Aug; 144(2):294-6. PubMed ID: 17659961
[TBL] [Abstract][Full Text] [Related]
19. Retinal pigment epithelium tears after bevacizumab injection.
Yeh B; Ferrucci S
Optometry; 2011 Mar; 82(3):152-7. PubMed ID: 21130699
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]